Phenotypic drug susceptibility characterization and clinical outcomes of tuberculosis strains with A-probe mutation by GeneXpert MTB/RIF

Phenotypic drug susceptibility characterization and clinical outcomes of tuberculosis strains with A-probe mutation by GeneXpert MTB/RIF

Abstract Background GeneXpert MTB/RIF (Xpert) assay was applied widely to detect Mycobacterium tuberculosis (MTB) and rifampicin resistance. Methods Retrospectively investigated the association among treatment histories, phenotypic drug susceptibility testing (pDST) results, and clinical outcomes of...

Full description

Bibliographic Details
Main Authors: Qi Nie, Dan Sun, Muxin Zhu, Shengjin Tu, Nanshan Chen, Hua Chen, Yong Zhou, Ge Yao, Xiaoqing Zhang, Tongcun Zhang, Chengfeng Yang, Lixuan Tao
Format: Article
Language:English
Published: BMC 2023-11-01
Series:BMC Infectious Diseases
Subjects:
Mycobacterium tuberculosis
Mutation
Rifampicin-resistant
GeneXpert MTB/RIF
Clinical outcome
Online Access:https://doi.org/10.1186/s12879-023-08509-0

Internet

https://doi.org/10.1186/s12879-023-08509-0

Similar Items